9
Opiate Receptor Pharmacology Donald R. Wesson, MD

Opiate Receptor Pharmacology Donald R. Wesson, MD

Embed Size (px)

Citation preview

Page 1: Opiate Receptor Pharmacology Donald R. Wesson, MD

Opiate Receptor Pharmacology

Donald R. Wesson, MD

Page 2: Opiate Receptor Pharmacology Donald R. Wesson, MD

Opiate Receptors and effect of Agonist

Mu1 (μ1) analgesia, euphoria

Mu2 (μ2) constipation, respiratory depression

Kappa spinal analgesia, dysphoria

Delta unknown

Page 3: Opiate Receptor Pharmacology Donald R. Wesson, MD

Schematic of Mu Opiate Receptor

Source: Goodman and Gillman 9th ed, p. 526

Page 4: Opiate Receptor Pharmacology Donald R. Wesson, MD

Receptor Binding at Mu receptor

Agonist

Partial Agonist

Antagonists

Morphine-like effect (e.g., heroin, weak binding except for Fentanyl)

Weak morphine-like effects with strong receptor affinity (e.g., buprenorphine)

No effect in absence of an opiate or opiate dependence (e.g., naltrexone)

Page 5: Opiate Receptor Pharmacology Donald R. Wesson, MD

Effect of Common Opiates at Mu Receptor

• Heroin, morphine, methadone

• Buprenorphine

• Naltrexone• Nalmefene

Agonists

Partial Agonist

Antagonist

Page 6: Opiate Receptor Pharmacology Donald R. Wesson, MD

Partial vs Full Opiate Mu Agonist

Dose of Opiate

OpiateEffect

death

Full Agonist(e.g., methadone)

Partial Agonist(e.g. buprenorphine)

Page 7: Opiate Receptor Pharmacology Donald R. Wesson, MD

Buprenorphine Pharmacology

• Partial agonist at mu receptor

• High affinity for mu receptor

• Can displace full opiate agonist such as heroin or methadone– Displacement of heroin or methadone by

buprenorphine can produce opiate withdrawal symptoms

Page 8: Opiate Receptor Pharmacology Donald R. Wesson, MD

Buprenorphine Pharmacology

• Antagonist at kappa receptor

• Poor bio-availability taken orally (extensive first pass metabolism)

• Much more bio-available from sublingual mucosa (Peak 2-3 hours following sublingual dose)

Page 9: Opiate Receptor Pharmacology Donald R. Wesson, MD